# AllergEase Inc: Form D filings

AllergEase Inc, a pharmaceuticals company in Danville, VA, filed 2 Form D notices with the SEC between 2013 and 2014. The latest, on April 3, 2014, reports $1.1 million sold of a $1.5 million offering to 42 investors.

Find out what AllergEase Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20AllergEase%20Inc%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=AllergEase%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Fallergease-inc-1569902)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20AllergEase%20Inc%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=AllergEase%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Fallergease-inc-1569902)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Virginia](https://specstream.ai/data/form-d/state/virginia): 771 rows, by operating companies, filed since November 1, 2024, $38.55, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/virginia
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 541 BRIDGE STREET, SUITE 2, Danville, VA, 24541
- Phone: (703) 926-7215
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2013
- Revenue range: $1,000,001 - $5,000,000
- Exemptions claimed: Rule 506(c)
- SEC identifier (CIK): 1569902

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Apr 3, 2014 | Amendment | $1,500,000 | $1,080,959 | $419,041 | 42 | Feb 4, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1569902/000121465914002588/0001214659-14-002588-index.htm) |
| Feb 19, 2013 | New notice | $1,500,000 | $407,500 | $1,092,500 | 7 | Feb 4, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1569902/000121465913000916/0001214659-13-000916-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Dan Nelson Engel | Director |  |
| Xandra Nelson Laskowski | Director |  |
| Luke Nelson Fry | Director |  |
| Omar Javery | Executive Officer, Director |  |
| Nancy Lai Sum Wong | Executive Officer, Director |  |
| Zeeshan Kaba | Executive Officer, Director |  |
| Sam Nelson Yousefzadeh | Director |  |

## Other pharmaceuticals companies in Virginia that filed recently

- [Quoin Pharmaceuticals Ltd.](https://specstream.ai/data/form-d/company/quoin-pharmaceuticals-ltd-1671502) $50 million · Sep 10, 2026

[Every Form D from the week of Mar 31, 2014](https://specstream.ai/data/form-d/week/2014-03-31) · [All recent filings in Virginia](https://specstream.ai/data/form-d/state/virginia) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what AllergEase Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).